Тревога и депрессия при хронической обструктивной болезни легких

1. Global Initiative for Chronic Obstructive Lung Diseases. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. (Revised 2011).
2. Смулевич А.Б. Депрессии в общей медицине. М.: Мед. информ. агентство, 2001.
3. Toft T et al. Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the Functional illness in Primary care (FIP) study. Psychol Med 2005; 35 (8): 1175–84.
4. Kagee A, Coyne JC, Palmer SC, Thompson R. Should we screen for depression? Caveats and potential pitfalls. Appl and Preventive Psychol 2000; 9 (2): 101–21.
5. Андрющенко А.В. Распространенность и структура психических расстройств в общей медицине. Психические расстройства в общей медицине. 2011; 1: 14–28.
6. Соловьева Э.Ю. Тревожные расстройства в общей медицинской практике. Cons. Med. 2008; 10 (2).
7. Международная статистическая классификация болезней и проблем, связанных со здоровьем. В 4 т. М.: Медицина, 2003.
8. Wiklund I et al. The Vicious Circle of COPD Exacerbations And The Overlooked Role Of Fear, Anxiety, And Depression. Am J Respir Crit Care Med 2011; 183: A2982.
9. Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med 2003; 65: 963–70.
10. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58: 65–70.
11. Hynninen KM, Breitve MH, Wiborg AB et al. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res 2005; 59: 429–43.
12. Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008; 31: 667–77.
13. Cafarella PA, Effing TW, Usmani Z-A, Frith PA. Treatments for anxiety and depression in patients with COPD: a literature review. Respir 2012; 17: 627–38.
14. Patton GC, Hibbert M, Rosier MJ et al. Is smoking associated with depression and anxiety in teenagers? Am J Public Health 1996; 86: 225–30.
15. Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149: 464–9.
16. Costi S, Brooks D, Goldstein RS. Perspectives that influence action plans for chronic obstructive pulmonary disease. Can Respir J 2006; 13: 362–8.
17. Bailey PH. The dyspnea-anxiety-dyspnea cycle – COPD patients’ stories of breathlessness: «It’s scary/When you can’t breathe». Qual Health Res 2004; 14: 760–78.
18. Rose C, Wallace L, Dickson R et al. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Educ Couns 2002; 47: 311–8.
19. Garuti G, Cilione C, Dell’Orso D et al. Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch Chest Dis 2003; 59: 56–61.
20. Ashmore JA, Emery CF, Hauck ER, MacIntyre NR. Marital adjustment among patients with chronic obstructive pulmonary disease who are participating in pulmonary rehabilitation. Heart Lung 2005; 34: 270–8.
21. Gudmundsson G, Gislason T, Janson C et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir Med 2006; 100: 87–93.
22. McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive disease: the importance of psychological factors. Eur Respir J 2002; 19: 47–53.
23. Zöckler N, Rief W, Kühl K, Kenn K. COPD-Specific Anxiety and Depressive Symptoms in COPD Patients. Pneumologie 2012; 66 (5): 290–6.
24. Hajiro T, Nishimura K, Tsukino M et al. Stages of disease severity and factors that affect then health status of patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 841–6.
25. Lustig FM, Haas A, Castillo R. Clinical and rehabilitation regime in patients with chronic obstructive pulmonary diseases. Arch Phys Med Rehabil 1972; 53: 315–22.
26. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002; 122: 1633–7.
27. Gudmundsson G, Gislason T, Janson C et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005; 26: 414–9.
28. Giordino ND et al. The impact of panic disorder on interoception and dyspnea reports in chronic obstructive pulmonary disease. Biol Psychol 2010; 84 (1): 142–6.
29. Norwood RJ. A review of etiologies of depression in COPD. Int J Chron Obstruct Pulmon Dis 2007; 2: 485–91.
30. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008; 85: 1–74.
31. Global Initiative for Chronic Obstructive Lung Diseases. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. (Updated 2008) 2010.
32. Yohannes AM. Depression and COPD in older people: a review and discussion. Br J Community Nurs 2005; 10: 42–6.
33. Maurer JM, Rebbapragada V, Borson S et al. Anxiety and depression in COPD. Current understanding, unanswered questions, and research needs. Chest 2008; 134 (4): 43S–56S.
34. Yohannes AM. Palliative care provision for patient with COPD. Health Qual. Life Outcomes 2007; 5: 17.
35. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004; 58: 65–70.
36. Manen JG, Bindels PJE, Decker FW et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 412–6.
37. Теслинов И.В. Психосоматические аспекты терапии больных хронической обструктивной болезнью легких: дис. ... канд. мед. наук. Воронеж, 2009.
38. Garuti G, Cilione C, Dell'Orso D et al. Impact of comprehensive pulmonary rehabilitation on anxiety and depression in hospitalized COPD patients. Monaldi Arch Chest Dis 2003; 59 (1): 56–61.
39. Galetskayte Y, Pushkarev D, Ovcharenko S, Volel B. COPD: Disease coping styles. Eur Respir J 2012; 40 (56): A1144.
40. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002; 122: 1633–7.
41. Almagro P, Barreiro B, O de Echaguen A et al. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 2006; 73: 311–7.
42. McSweeny AJ, Grant I, Heaton RK et al. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med 1982; 142: 473–8.
43. Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med 1984; 144: 1613–9.
44. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St George’s Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321–7.
45. Felker B, Katon W, Hedrick SC et al. The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry 2001; 23: 56–61.
46. Gudmundsson G, Gislason T, Janson C et al. Depression, anxiety and health status after hospitalisation for COPD a multicentre study in the Nordic countries. Respir Med 2006; 100: 87–93.
47. Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry 2003; 18: 412–6.
48. Cully JA, Graham DP, Stanley MA et al. Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression. Psychosomatics 2006; 47: 312–9.
49. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34: 491–6.
50. Almagro P, Calbo E, Ochoa de EA et al. Mortality after hospitalization for COPD. Chest 2002; 121: 1441–8.
51. Fan VS, Ramsey SD, Giardino ND et al. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med 2007; 167: 2345–53.
52. Fan VS, Curtis JR, Tu SP et al. Using quality of life to predict hospitalization and mortality in patients with obstructive lung diseases. Chest 2002; 122: 429–36.
53. Bosley CM, Corden ZM, Rees PJ et al. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J 1996; 9: 2346–50.
54. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278–85.
55. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–7.
56. Katon WJ. The Institute of Medicine «Chasm» report: implications for depression collaborative care models. Gen Hosp Psychiatry 2003; 25: 222–9.
57. Lin EH, Katon W, Von KM et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154–60.
58. Blumenthal JA, Williams RS, Wallace AG et al. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 1982; 44: 519–27.
59. Marcus MD, Wing RR, Guare J et al. Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diabetes Care 1992; 15: 253–5.
60. Stapleton RD, Nielsen EL, Engelberg RA et al. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest 2005; 127: 328–34.
61. Kunik ME, Roundy K, Veazey C et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005; 127: 1205–11.
62. Tashkin DP, Kanner R, Bailey W et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. The Lancet 2001; 357: 1571–5.
63. Tjitze S. Hoekstra. Screening Anxiety and Depression with COPD Patients. Presentation 2012; nursinglibrary.org
64. Lustig FM, Haas A, Castillo R. Clinical and rehabilitation regime in patients with chronic obstructive pulmonary diseases. Arch Phys Med Rehabil 1972; 53: 315–22.
65. Dahlen I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest 2002; 122: 1633–7.
66. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys 2007; 43 (4): 475–85.
67. Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. J Psychosom Res 2007; 63 (5): 551–65.
68. Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr Opin Pulm Med 2009; 15 (2): 143–9.
69. Man WD, Polkey MI, Donaldson N et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004; 329 (7476): 1209.

С.И.Овчаренко, Я.К.Галецкайте

ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава РФ